Par Formulations Private Limited
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- India
- Registered address
- 9/215, Pudupakkam-Vandalur Main Road, Pudupakkam, Kelambakkam,,, Chennai, Tamil Nadu 603103, India (IND)
- Operations here
- analysismanufacturepack
- FDA identifiers
- FEI 3007027193 · DUNS 676159161
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2026-06-10
- NAIDrug Quality Assurance2023-03-24
- NAIDrug Quality Assurance2019-06-21
- VAIDrug Quality Assurance2016-12-07
- NAIDrug Quality Assurance2015-04-17
- NAIDrug Quality Assurance2013-10-17
- NAIDrug Quality Assurance2011-09-21
Drugs this plant is listed as making
3 distinct drugs across 9 products name this site in their FDA label.
- dantrolene sodiumEndo USA, Inc.
- perphenazineEndo USA, Inc.
- sapropterin dihydrochloridePar Health USA, LLC
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.